Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous methylprednisolone and tear film changes in thyroid-associated ophthalmopathy
2012-001910-40Phase 3Completed
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of methylprednisolone in Graves Orbitopathy (GO) and Graves' disease, sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoints: Change in tear film thickness and Tear film break-up time (BUT). Started Apr 2012; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Graves Orbitopathy (GO)Graves' disease
Beyond the preview
Go deeper on 2012-001910-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001910-40.